Table 6.

Distribution of Deaths - NSABP STAR Trial (P-2)

Cause of deathDeaths, n
    Bone, articular cartilage and connective tissue11
    Endocrine gland01
    Other, uncertain, and unspecified sites511
Circulatory/vascular disease4242
    Cerebrovascular disease, unspecified10
    Hypertensive disease14
    Ischemic heart disease138
    Other heart disease914
    Peripheral vascular disease, unspecified01
    Polyarteritis nodosa01
    Pulmonary embolism32
    Primary pulmonary hypertension10
    Accident, auto34
    Accident, fire10
    Alcohol dependence syndrome11
    Asphyxiation and strangulation10
    Complications of surgery01
    Disorders of metabolism10
    Injury, intracranial22
    Injury, other10
    Interferon toxicity01
    Intestinal infectious disease01
    Other conditions of the blood02
    Other conditions of the brain/neurological system73
    Other diseases of the digestive system76
    Other Diseases of the urinary system21
    Other respiratory disease137
    Skin infections01
    Symptoms, signs, and ill-defined conditions23
Total deaths (rate per 1,000)236 (3.81)202 (3.22)
    Risk ratio (95% CI)0.70–1.02)

Abbreviations: CI, confidence interval; NSABP STAR, National Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene.